The correlation between PrPC, iron, and glucose homeostasis is likely to provide new, untapped therapeutic opportunities for type-2-diabetes, AD, and other neurodegenerative conditions associated with iron dyshomeostasis. The gene discussed is PRNP; the disease is Alzheimer disease.